… of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide
CF Deacon, MA Nauck, J Meier… - The Journal of …, 2000 - academic.oup.com
Gastric inhibitory polypeptide (GIP) is susceptible to degradation, but only recently has
dipeptidyl peptidase IV been identified as the enzyme responsible. Most RIAs recognize
both intact GIP-(1–42) and the noninsulinotropic N-terminally truncated metabolite, GIP-(3–
dipeptidyl peptidase IV been identified as the enzyme responsible. Most RIAs recognize
both intact GIP-(1–42) and the noninsulinotropic N-terminally truncated metabolite, GIP-(3–
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论